DTaP-IPV Candidate Vaccine

diphtheria and tetanus toxoids and acellular pertussis and inactivated poliovirus vaccine (DTaP-IPV) · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DTaP-IPV Candidate Vaccine, covering 2016-09-15 to 2020-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines [Phase 3]

See pricing